Xiao-Fang Yu
7PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 30, 2026
Reinvigorating COTL1high NK cells via GITR signalling overcomes immune checkpoint blockade resistance in tsMHC-I-impaired tumours.Wenhua You, Chupeng Hu, Yuhan Zhang
|Dec 14, 2025
Selective depletion of tumor-associated SAMHD1 enhances chemotherapeutic efficacy and antitumor immune responses.Jing Sun, Wenwen Zheng, Zheng-Guo Zhang
|Mar 09, 2023
The SARS-CoV-2 main protease induces neurotoxic TDP-43 cleavage and aggregates.Jiaxin Yang, Yan Li, Shijin Wang
|Feb 23, 2023
TRAF3 activates STING-mediated suppression of EV-A71 and target of viral evasion.Wenwen Zheng, Zhenbang Zhou, Yajuan Rui
|Mar 16, 2021
Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins.Yajuan Rui, Jiaming Su, Si Shen
|Oct 30, 2019
HIV-2/SIV Vpx targets a novel functional domain of STING to selectively inhibit cGAS-STING-mediated NF-κB signalling.Jiaming Su, Yajuan Rui, Meng Lou
Pageof 2
